Robert W. Nickeson, MD

Dr. Nickeson began his career as an Assistant Professor in Pediatric Rheumatology at the University of Oklahoma, College of Medicine in 1981. Dr. Nickeson is currently an Assistant Professor, with joint appointments in Pediatrics and Internal Medicine at the University of South Florida. In 2004 he was appointed Director of the Rheumatology program, Division of Allergy, Immunology, and Rheumatology, in the Department of Pediatrics.

Education & Training

Board Certifications

• American Board of Pediatrics
• Pediatric Rheumatology

Scholarly Activity

• Principal investigator: Open label extension treatment with TNFR: Fc for participating patients in TNFR: Fc clinical trials. Sponsor: Immunex Corp. and Amgen Inc. 2003-2008.
• Principal investigator. Macrophage responses to joint-specific stimuli: Development of a novel molecular classification scheme for Juvenile Rheumatoid Arthritis/Juvenile Idiopathic Arthritis. Sponsor: Pediatric Clinical Research Center, All Children’s Hospital, St. Petersburg, FL. 2005-2007.
• Principal investigator: CARRA Enhanced Drug Safety Surveillance Project in Juvenile Rheumatoid and Idiopathic Arthritis (JRA/JIA). 2008.
• Co-investigator: Characterization of novel polyreactive anti-HIV antibodies in autoimmunity. Sponsor: National Institute of Health. 2008-2010.

Selected Publications

E H Giannini, E J Brewer, M L Miller et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Journal of Pediatrics, 1990, 117 (4): 645-52. Participating center for Pediatric Rheumatology Collaborative Study Group.

E H Giannini, K S Barron, C H Spencer et al. Auranofin Therapy for Juvenile Rheumatoid Arthritis: Results of a Five- Year Open Label Extension Trial. Journal of Rheumatology, 1991; 18 (8): 1240-42. Participating center for Pediatric Rheumatology Collaborative Study Group.